Cargando…
MAGE-A Antigens and Cancer Immunotherapy
MAGE-A antigens are expressed in a variety of cancers of diverse histological origin and germinal cells. Due to their relatively high tumor specificity, they represent attractive targets for active specific and adoptive cancer immunotherapies. Here, we (i) review past and ongoing clinical studies ta...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340762/ https://www.ncbi.nlm.nih.gov/pubmed/28337438 http://dx.doi.org/10.3389/fmed.2017.00018 |
_version_ | 1782512862475845632 |
---|---|
author | Zajac, Paul Schultz-Thater, Elke Tornillo, Luigi Sadowski, Charlotte Trella, Emanuele Mengus, Chantal Iezzi, Giandomenica Spagnoli, Giulio C. |
author_facet | Zajac, Paul Schultz-Thater, Elke Tornillo, Luigi Sadowski, Charlotte Trella, Emanuele Mengus, Chantal Iezzi, Giandomenica Spagnoli, Giulio C. |
author_sort | Zajac, Paul |
collection | PubMed |
description | MAGE-A antigens are expressed in a variety of cancers of diverse histological origin and germinal cells. Due to their relatively high tumor specificity, they represent attractive targets for active specific and adoptive cancer immunotherapies. Here, we (i) review past and ongoing clinical studies targeting these antigens, (ii) analyze advantages and disadvantages of different therapeutic approaches, and (iii) discuss possible improvements in MAGE-A-specific immunotherapies. |
format | Online Article Text |
id | pubmed-5340762 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-53407622017-03-23 MAGE-A Antigens and Cancer Immunotherapy Zajac, Paul Schultz-Thater, Elke Tornillo, Luigi Sadowski, Charlotte Trella, Emanuele Mengus, Chantal Iezzi, Giandomenica Spagnoli, Giulio C. Front Med (Lausanne) Medicine MAGE-A antigens are expressed in a variety of cancers of diverse histological origin and germinal cells. Due to their relatively high tumor specificity, they represent attractive targets for active specific and adoptive cancer immunotherapies. Here, we (i) review past and ongoing clinical studies targeting these antigens, (ii) analyze advantages and disadvantages of different therapeutic approaches, and (iii) discuss possible improvements in MAGE-A-specific immunotherapies. Frontiers Media S.A. 2017-03-08 /pmc/articles/PMC5340762/ /pubmed/28337438 http://dx.doi.org/10.3389/fmed.2017.00018 Text en Copyright © 2017 Zajac, Schultz-Thater, Tornillo, Sadowski, Trella, Mengus, Iezzi and Spagnoli. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Zajac, Paul Schultz-Thater, Elke Tornillo, Luigi Sadowski, Charlotte Trella, Emanuele Mengus, Chantal Iezzi, Giandomenica Spagnoli, Giulio C. MAGE-A Antigens and Cancer Immunotherapy |
title | MAGE-A Antigens and Cancer Immunotherapy |
title_full | MAGE-A Antigens and Cancer Immunotherapy |
title_fullStr | MAGE-A Antigens and Cancer Immunotherapy |
title_full_unstemmed | MAGE-A Antigens and Cancer Immunotherapy |
title_short | MAGE-A Antigens and Cancer Immunotherapy |
title_sort | mage-a antigens and cancer immunotherapy |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340762/ https://www.ncbi.nlm.nih.gov/pubmed/28337438 http://dx.doi.org/10.3389/fmed.2017.00018 |
work_keys_str_mv | AT zajacpaul mageaantigensandcancerimmunotherapy AT schultzthaterelke mageaantigensandcancerimmunotherapy AT tornilloluigi mageaantigensandcancerimmunotherapy AT sadowskicharlotte mageaantigensandcancerimmunotherapy AT trellaemanuele mageaantigensandcancerimmunotherapy AT menguschantal mageaantigensandcancerimmunotherapy AT iezzigiandomenica mageaantigensandcancerimmunotherapy AT spagnoligiulioc mageaantigensandcancerimmunotherapy |